Table 5.
The results of OncoAim®-NGS of CNB samples
| NGS | Classification of CNB samples based on morphology, no | |||
|---|---|---|---|---|
| Indeterminate lesion | Follicular neoplasm | Suspicious for malignancy | Total | |
| Negative | 15 | 19 | 5 | 39 |
| BRAF V600E | 12 | 0 | 29 | 41 |
| PTEN mutation | 0 | 1 | 0 | 1 |
| ALK fusion | 1 | 0 | 0 | 1 |
| RET fusion | 5 | 1 | 1 | 7 |
| NTRK fusion | 4 | 0 | 0 | 4 |
| RAS mutation | 3 | 5 | 0 | 8 |
| PPARγ fusion | 0 | 1 | 0 | 1 |
| TERT mutation | 0 | 4 | 0 | 4 |
| Non-V600E BRAF mutation | 0 | 1 | 0 | 1 |
| Total | 40 | 32 | 35 | 107 |
CNB, core needle biopsy; NGS, next-generation sequencing